Status message

Zimmer Biomet: FCPA probe remains ongoing

Medical device maker Zimmer Biomet Holdings (formerly Biomet) said last week in a securities filing that it’s still under investigation by the Department of Justice and Securities and Exchange Commission for possible violations of the Foreign Corrupt Practices Act regarding its operations in Brazil and Mexico.

As Compliance Week previously reported, Biomet entered into a three-year deferred prosecution agreement in 2012 with the Justice Department, and a parallel consent agreement with the SEC, for possible violations of the FCPA. Then, in October 2013, Biomet...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.

Free 5-Day Trial

Try subscriber benefits free . . .

Leave this field blank

LinkedIn Group

Join the Compliance Week LinkedIn group, where members network and discuss GRC news and issues. Open to compliance professionals.